JP2016506412A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506412A5
JP2016506412A5 JP2015549900A JP2015549900A JP2016506412A5 JP 2016506412 A5 JP2016506412 A5 JP 2016506412A5 JP 2015549900 A JP2015549900 A JP 2015549900A JP 2015549900 A JP2015549900 A JP 2015549900A JP 2016506412 A5 JP2016506412 A5 JP 2016506412A5
Authority
JP
Japan
Prior art keywords
cancer
flightless
subject
level
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015549900A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016506412A (ja
JP6487849B2 (ja
Filing date
Publication date
Priority claimed from AU2013202668A external-priority patent/AU2013202668B2/en
Application filed filed Critical
Publication of JP2016506412A publication Critical patent/JP2016506412A/ja
Publication of JP2016506412A5 publication Critical patent/JP2016506412A5/ja
Application granted granted Critical
Publication of JP6487849B2 publication Critical patent/JP6487849B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015549900A 2012-12-24 2013-12-20 癌の増殖及び転移の阻害 Expired - Fee Related JP6487849B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2012905692 2012-12-24
AU2012905692A AU2012905692A0 (en) 2012-12-24 Inhibition of cancer growth and metastasis
AU2013202668 2013-04-05
AU2013202668A AU2013202668B2 (en) 2012-12-24 2013-04-05 Inhibition of cancer growth and metastasis
PCT/AU2013/001498 WO2014100852A1 (en) 2012-12-24 2013-12-20 Inhibition of cancer growth and metastasis

Publications (3)

Publication Number Publication Date
JP2016506412A JP2016506412A (ja) 2016-03-03
JP2016506412A5 true JP2016506412A5 (enExample) 2017-02-16
JP6487849B2 JP6487849B2 (ja) 2019-03-20

Family

ID=51019569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015549900A Expired - Fee Related JP6487849B2 (ja) 2012-12-24 2013-12-20 癌の増殖及び転移の阻害

Country Status (6)

Country Link
US (2) US9895414B2 (enExample)
EP (1) EP2934499A4 (enExample)
JP (1) JP6487849B2 (enExample)
AU (1) AU2013202668B2 (enExample)
CA (1) CA2896261A1 (enExample)
WO (1) WO2014100852A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016040987A1 (en) * 2014-09-15 2016-03-24 Abregen Pty Ltd Treating and/or preventing psoriasis
EP3204500B1 (en) * 2014-10-07 2019-05-08 Council of Scientific and Industrial Research Aptamers for purifying and quantifying gelsolin and its variants
CN105132357B (zh) * 2015-07-29 2019-12-06 苏州诺普再生医学有限公司 一种用于表皮细胞培养的无血清培养体系
US11236337B2 (en) 2016-11-01 2022-02-01 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
WO2020077397A1 (en) * 2018-10-15 2020-04-23 Abregen Pty Ltd Methods and compositions for the treatment of mucosal lesions
WO2021262919A2 (en) 2020-06-26 2021-12-30 The Research Foundation For The State University Of New York 5-halouracil-modified micrornas and their use in the treatment of cancer
US20250173863A1 (en) * 2023-10-27 2025-05-29 Northwestern University Methods and systems relating to artificial intelligence for early recognition of rare skin diseases

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5258498A (en) 1987-05-21 1993-11-02 Creative Biomolecules, Inc. Polypeptide linkers for production of biosynthetic proteins
DE68927933T2 (de) 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
SE462454B (sv) 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
AU7247191A (en) 1990-01-11 1991-08-05 Molecular Affinities Corporation Production of antibodies using gene libraries
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
PT100379B (pt) 1991-04-10 1999-01-29 Scripps Research Inst Bibliotecas de receptores heterodimericos usando fagomideos
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
PT700521E (pt) 1993-05-28 2003-10-31 Baylor College Medicine Metodo e espectrometro de massa para dessorcao e ionizacao de analitos
JPH09506262A (ja) 1993-12-08 1997-06-24 ジェンザイム・コーポレイション 特異的抗体の製造方法
ES2201097T3 (es) 1994-01-31 2004-03-16 Trustees Of Boston University Bibliotecas de anticuerpos policlonales.
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6251588B1 (en) 1998-02-10 2001-06-26 Agilent Technologies, Inc. Method for evaluating oligonucleotide probe sequences
EP1068356B8 (en) 1998-04-03 2007-01-03 Adnexus Therapeutics, Inc. Addressable protein arrays
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
AU4025300A (en) 1999-03-24 2000-10-09 Packard Bioscience Company Continuous porous matrix arrays
EP1456668B1 (en) 2001-12-05 2007-05-02 Sense Proteomic Limited Protein arrays for allelic variants and uses thereof
AU2002359791A1 (en) * 2001-12-21 2003-07-30 Diadexus, Inc. Compositions and methods relating to urinary specific genes and proteins
US7276381B2 (en) 2002-01-25 2007-10-02 Bio-Rad Laboratories, Inc. Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes
US20050260639A1 (en) 2002-09-30 2005-11-24 Oncotherapy Science, Inc. Method for diagnosing pancreatic cancer
EP1945256B1 (en) * 2005-10-25 2012-07-04 Women's & Children's Health Research Institute Methods and compositions for improving wound repair
US20070248628A1 (en) * 2005-12-06 2007-10-25 Keller Lorraine H Immunogens in cancer stem cells
EP2012127A3 (en) 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnostic markers for detecting prostate cancer
US20090098535A1 (en) * 2007-07-31 2009-04-16 Institut Pasteur Upregulation of rack-1 in melanoma and its use as a marker
WO2011113085A1 (en) 2010-03-17 2011-09-22 Adelaide Research & Innovation Pty Ltd A sensor and a method for characterising a dielectric material

Similar Documents

Publication Publication Date Title
Kok et al. Cancer-derived exosomes: their role in cancer biology and biomarker development
Loboda et al. A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
Yuan et al. MiR‐940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients
Ng et al. Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
Liu et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma
Chen et al. The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis
CN106456694B (zh) 与循环肿瘤细胞相关的方法和测定法
Zhu et al. MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis
Lv et al. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma
Dai et al. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma
CN102421919B (zh) 采用Axl作为上皮‑间质转化的生物标志物的方法
Liu et al. Role of circular RNAs in cancer therapy resistance
Yan et al. Role of exosomes in pancreatic cancer
ES2877757T3 (es) Tratamiento terapéutico de cáncer de mama basado en el estado de c-MAF
JP2015521050A5 (enExample)
JP2007506426A5 (enExample)
Wang et al. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9
US10526656B2 (en) Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
US20200017914A1 (en) Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
WO2006024283A3 (de) Verbindungen und methoden zur behandlung, diagnose und prognose bei pankreaserkrankungen
JP6110346B2 (ja) miR−31に関連する組成物および方法
JP2017525337A5 (enExample)
Bukhari et al. PINTology: A short history of the lncRNA LINC‐PINT in different diseases
JP2017527533A5 (enExample)
Lian et al. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer